GLP-1 receptor agonist
A once-weekly GLP-1 receptor agonist used in type 2 diabetes.
Supported by large clinical trials for its registered diabetes indications.
Gastrointestinal side effects are common; prescribers screen for contraindications and monitor use.
A registered prescription medicine in Australia for defined indications, supplied via prescription and pharmacy.
Lawful access is via prescription and pharmacy dispensing of the registered product.
This entry is general information about Dulaglutide, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.